PT0511 drug page Clinical trials

Trials with PT0511

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
2Countries
210Planned patients

Showing 1–1 of 1

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Recruiting Phase 1 210 patients NCT07300150

The primary purpose of this study is to evaluate the safety and tolerability, determine the maximally tolerated dose (MTD) and/or recommended Phase 2 dose(s) (RP2D) of PT0511 in adult participants with solid tumors as monotherapy and in co…

United States, South Korea Nov 2025 – Oct 2028 Interventional
Combined with: Cetuximab

Where the recruiting trials are